Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.
Journal: PLoS pathogens
Published: October 31, 2024
A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.
Journal: bioRxiv : the preprint server for biology
Published: August 30, 2024
A First Presentation of Autoimmune Primary Adrenal Insufficiency.
Journal: The American journal of medicine
Published: August 18, 2023
A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 15, 2020
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Journal: PLoS neglected tropical diseases
Published: December 21, 2018
Showing 1-7 of 7
Last Updated: 09/26/2026